Rybelsus (semaglutide) Tablets 7 mg, 30 Tablets Per Bottle (Rx)
(Note: We don’t Fill Personal Prescriptions)
How to Order:
You will receive instructions on how to create an account along with Rx Ordering Details.
Rybelsus (semaglutide) Tablets, 7 mg, by Novo Nordisk, are an innovative oral medication designed to help manage blood sugar levels in adults with type 2 diabetes. This once-daily tablet offers a convenient alternative to injectable therapies, aiding in effective glycemic control as part of a comprehensive diabetes management plan.
Details and Features:
- Product Name: Rybelsus (semaglutide) Tablets
- Dosage Strength: 7 mg
- Quantity: 30 Tablets per bottle
- Usage: Oral administration
- Indication: Type 2 diabetes management
-
Features:
- Once-daily dosing for enhanced convenience
- Proven efficacy in improving glycemic control
- Supports weight management along with diet and exercise
- Manufacturer: Novo Nordisk
Mechanism of Action:
Rybelsus contains semaglutide, a GLP-1 receptor agonist. It mimics the action of the natural hormone GLP-1, enhancing insulin secretion when blood sugar levels are high, reducing glucagon release, and slowing gastric emptying. This results in improved blood sugar control and can aid in weight loss.
Directions for Use:
- Dosing: Take one tablet orally once daily.
- Timing: Administer on an empty stomach, at least 30 minutes before the first meal of the day with no more than 4 ounces of plain water.
- Swallowing: Swallow tablets whole without splitting, crushing, or chewing.
- Consistency: Take consistently at the same time each day for best results.
- Adjustment: Follow physician instructions for dosage adjustments based on response and tolerance.
Warnings:
- Thyroid Tumors: May cause or exacerbate thyroid tumors, including cancer. Not suitable for patients with a personal or family history of medullary thyroid carcinoma.
- Pancreatitis: Risk of acute pancreatitis; discontinue if suspected.
- Renal Function: Monitor in patients with renal impairment.
- Hypersensitivity: Potential for allergic reactions; discontinue if observed.
- Pregnancy: Not recommended for use during pregnancy or breastfeeding.
Side Effects:
- Common: Nausea, vomiting, diarrhea, abdominal pain, constipation.
- Serious: Hypoglycemia, particularly when used with insulin or sulfonylureas, pancreatitis, kidney problems, allergic reactions.
Rybelsus (semaglutide) Tablets provide a breakthrough oral option for managing type 2 diabetes, delivering both convenience and efficacy while supporting overall health and well-being under a healthcare provider's guidance.